These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Use and misuse of hormones in sport. Sonksen PH; Cowan D; Holt RI Lancet Diabetes Endocrinol; 2016 Nov; 4(11):882-883. PubMed ID: 27542991 [No Abstract] [Full Text] [Related]
27. Doping analysis on solid ground. Hemmersbach P; Drange M; Rabin O; Botrè F; Dehnes Y Tidsskr Nor Laegeforen; 2012 Jan; 132(2):130. PubMed ID: 22278263 [No Abstract] [Full Text] [Related]
28. Performance enhancement: To embrace doping in sport is absurd. Purcell R Nature; 2012 Aug; 488(7410):157. PubMed ID: 22874954 [No Abstract] [Full Text] [Related]
29. Doping analyses are not on safe ground. Østerud B; Skotland T Tidsskr Nor Laegeforen; 2012 Apr; 132(8):929-30. PubMed ID: 22562317 [No Abstract] [Full Text] [Related]
30. Advances in sports drug testing: an overview. Kazlauskas R Drug Test Anal; 2010; 2(11-12):523-5. PubMed ID: 21204284 [No Abstract] [Full Text] [Related]
32. Advances in equine sports testing. Kuuranne T Drug Test Anal; 2011 Jan; 3(1):18. PubMed ID: 21254453 [No Abstract] [Full Text] [Related]
33. Current implementation and future of the Athlete Biological Passport. Sottas PE; Vernec A Bioanalysis; 2012 Jul; 4(13):1645-52. PubMed ID: 22831480 [TBL] [Abstract][Full Text] [Related]
34. Anthony P. Millar on Michael Bahrke's Performance-enhancing substance misuse in sport: risk factors and considerations for intervention programs. Millar AP Subst Use Misuse; 2012; 47(13-14):1519-20. PubMed ID: 23186457 [No Abstract] [Full Text] [Related]
35. The 32nd Manfred Donike workshop on doping analysis. Gmeiner G Drug Test Anal; 2014; 6(11-12):1085-6. PubMed ID: 25516449 [No Abstract] [Full Text] [Related]
36. Marijuana use in athletics. Stoll DB R I Med J (2013); 2014 Jan; 98(1):13. PubMed ID: 25562053 [No Abstract] [Full Text] [Related]
37. Azenildo Moura Santos on Michael Bahrke's "Performance-enhancing substance misuse in sport: risk factors and considerations for success and failure in intervention programs". Santos AM Subst Use Misuse; 2012; 47(13-14):1517-8. PubMed ID: 23186456 [No Abstract] [Full Text] [Related]
38. [Organic injuries in doped elite sports men]. Vitoria Ortiz M An R Acad Nac Med (Madr); 2010; 127(2):289-302; discussion 303-5. PubMed ID: 21877411 [TBL] [Abstract][Full Text] [Related]
39. Challenges and perspectives in anti-doping testing. Schamasch P; Rabin O Bioanalysis; 2012 Jul; 4(13):1691-701. PubMed ID: 22831484 [TBL] [Abstract][Full Text] [Related]
40. Analytical progresses of the International Olympic Committee and World Anti-Doping Agency Olympic laboratories. Georgakopoulos C; Saugy M; Giraud S; Robinson N; Alsayrafi M Bioanalysis; 2012 Jul; 4(13):1549-63. PubMed ID: 22831472 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]